Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01570491 · ClinicalTrials.gov registry record · NA

A Real-Time Ultrasound Guided Approach For Spinal Anesthesia

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT01570491: Completed NA study, sponsored by The Cleveland Clinic.

NCT01570491 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01570491, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

Our goal was to compare the number of attempts to perform spinal anesthesia using real-time ultrasound guidance versus landmark technique in patients meeting predefined criteria for difficult spinal anesthesia.

Primary Outcome

Number of attempts (defined as number of needle reinsertions form the skin and NOT number of redirection of the needle) at the beginning of surgery

Interventions

  • OTHER ultrasound-guided spinal anesthesia
  • OTHER standard spinal anesthesia

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2012-03
Est. Completion 2016-12
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT01570491 record still lists

NCT01570491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which ultrasound-guided spinal anesthesia is the first listed.

NCT01570491 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01570491 about?

NCT01570491 is a clinical study titled "A Real-Time Ultrasound Guided Approach For Spinal Anesthesia". Our goal was to compare the number of attempts to perform spinal anesthesia using real-time ultrasound guidance versus landmark technique in patients meeting predefined criteria for difficult spinal anesthesia.

What is the current status of trial NCT01570491?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2012-03. Estimated completion is 2016-12.

What interventions are being tested in trial NCT01570491?

The interventions under investigation include: ultrasound-guided spinal anesthesia (OTHER), standard spinal anesthesia (OTHER).

Who is sponsoring clinical trial NCT01570491?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01570491's enrollment target sits among peer trials

38 1538th of 2000 higher than 461 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01570491, the US trial registry maintained by the National Library of Medicine. NCT01570491 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.